United Therapeutics (UTHR) Inventory (2009 - 2026)

United Therapeutics has disclosed Inventory across 18 years of filings, most recently posting $193.8 million for Q2 2026.

• In Q2 2026, Inventory rose 14.54% year-over-year to $193.8 million; the TTM figure through Jun 2026 stood at $193.8 million (up 14.54% YoY), while the FY2025 annual figure was $183.1 million, up 15.96% from the prior year.
• Inventory came in at $193.8 million for Q2 2026 at United Therapeutics, up from $178.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $193.8 million in Q2 2026 to a low of $88.2 million in Q1 2022.
• Average Inventory over 5 years is $134.5 million, with a median of $128.4 million recorded in 2024.
• Year-over-year, Inventory decreased 5.89% in 2022 and surged 41.23% in 2024.
• Over 5 years, Inventory stood at $102.0 million in 2022, then increased by 9.61% to $111.8 million in 2023, then surged by 41.23% to $157.9 million in 2024, then advanced by 15.96% to $183.1 million in 2025, then climbed by 5.84% to $193.8 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $193.8 million in Q2 2026, $178.3 million in Q1 2026, and $183.1 million in Q4 2025.